ASCO: Adjuvant Atezolizumab for High-Risk Muscle-Invasive Bladder Cancer

preview_player
Показать описание
Petros Grivas MD, PhD interview on Adjuvant Atezolizumab for High-Risk Muscle-Invasive Bladder Cancer.

--

Follow PracticeUpdate:

Рекомендации по теме